Engineering Sandoz Inaugurates New Antibiotic Production Plant in Austria

Source: Press release Sandoz 2 min Reading Time

Related Vendors

The new unit is expected to increase the company’s production capacity by 20 % as compared to the current capacity of 200 million packages per year. The site will also enable the production of one billion additional penicillin tablets and a doubling of the quantity of powder oral suspensions which are mainly used in pediatric medicines.

Sandoz has opened a new production facility in Kundl, Austria, to serve more patients with affordable life-saving drugs produced entirely in Europe.(Source:  Sandoz)
Sandoz has opened a new production facility in Kundl, Austria, to serve more patients with affordable life-saving drugs produced entirely in Europe.
(Source: Sandoz)

Basel/Switzerland – Sandoz has opened a new production facility in Kundl, Austria, to serve more patients with affordable life-saving drugs produced entirely in Europe. The new facility and automated production lines will increase production capacity by 20 % compared to the current capacity of 200 million packages per year. The expansion in finished dosage forms means that Kundl now has a production capacity of 240 million packages per year, more than a doubling from 2021 output levels.

Gilbert Ghostine, Chairman Sandoz, said: "Antibiotics are the backbone of modern medicine and Kundl is a testament to the resilience of European manufacturing. We are proud to further strengthen our manufacturing capabilities in Austria. This allows us to address growing demand and further strengthens our commitment to our unique European-based antibiotic production network."

With a manufacturing area of 3,000m2, innovative technologies enable the production of one billion additional penicillin tablets and a doubling of the quantity of powder oral suspensions (POS), which are mainly used in pediatric medicines.

Stay up to Date

Do you want the latest news, specialist articles and information on new products? Then you can register for our free newsletter:

Choose your Newsletter

This project is another step in the Sandoz commitment to Austria as an integral part of its sustainable and high-quality European-based production network.

Sandoz has the only major remaining vertically integrated production network for penicillin in Europe. From active pharmaceutical ingredients (API) to finished dosage forms (FDF), Sandoz produces penicillin—the leading category of antibiotics worldwide—in Austria.

The opening of the new facility is part of a 200-million-euro investment into the site in Kundl, to significantly upgrade penicillin API manufacturing and increase output of finished products, in order to better serve patients in more than 100 countries worldwide.

Richard Saynor, CEO Sandoz, said: "Kundl, as the hub and center of our antibiotic production, is a true lighthouse project when it comes to security of antibiotic supply. This investment is our contribution to fighting shortages and increasing access for patients. To be successful in the future, we need to join forces across healthcare systems and build a sustainable market environment for generic medicines, focused on what is best for patients."

(ID:49976593)

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy. The consent declaration relates, among other things, to the sending of editorial newsletters by email and to data matching for marketing purposes with selected advertising partners (e.g., LinkedIn, Google, Meta)

Unfold for details of your consent